文献速递鼻科

内镜鼻窦手术围手术期镇痛的循证综述

Perioperative analgesia for patients undergoing endoscopic sinus surgery: an evidence-based review.
PubMed 文献 · Int Forum Allergy Rhinol · 2018-04-12

对乙酰氨基酚不良事件少并减少术后即刻阿片类补救需求,NSAIDs亦减少术后阿片类消耗且汇总证据为A级。结论支持NSAIDs和加巴喷丁用于术后疼痛控制,对乙酰氨基酚、α受体激动剂和局麻药也是可选方案。

要点

  • 对乙酰氨基酚不良事件少,可减少鼻窦术后即刻阿片类补救需求。
  • NSAIDs减少术后阿片类消耗,汇总证据等级为A级。
  • 加巴喷丁有证据支持用于内镜鼻窦术后疼痛控制。

核心结论

  • 有证据支持NSAIDs和加巴喷丁用于内镜鼻窦手术后的疼痛控制。
  • 对乙酰氨基酚、α受体激动剂和局麻药也是术后镇痛的可选方案。

研究设计与样本

  • 系统循证综述,检索PubMed/MEDLINE、Cochrane Library和EmBase数据库中内镜鼻窦手术后镇痛药相关研究。

主要发现

  • GRADE标准判定总体证据质量为中等。
  • 对乙酰氨基酚不良事件少,减少鼻窦术后即刻阿片类补救需求,获益大于危害。
  • NSAIDs减少术后阿片类消耗,但小部分鼻窦手术患者可能存在NSAID不耐受。
  • 评价NSAIDs的研究汇总证据等级为A级,其他几种药物的汇总证据等级为B级。

关键数值与推荐

  • NSAIDs汇总证据等级为A级。
  • 其他几种药物汇总证据等级为B级。
  • 总体证据质量按GRADE标准为中等。

临床怎么用

  • 可优先考虑NSAIDs和加巴喷丁控制内镜鼻窦术后疼痛。
  • 对乙酰氨基酚、α受体激动剂和局麻药可作为术后镇痛替代选择。
  • 熟悉上述数据有助于促进阿片类替代药物的使用。

局限性

  • 需要进一步大规模、多机构、随机试验以提供这些围手术期镇痛药的确定性推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Misuse and diversion of prescription opioids have been critical in facilitating the opioid epidemic. Our objective was to perform a systematic evidence-based review delineating perioperative regimens (including opioid alternatives) evaluated for endoscopic sinus surgery. METHODS: PubMed/MEDLINE, Cochrane Library, and EmBase databases were evaluated for studies detailing analgesics employed after endoscopic sinus surgery. Studies were assessed for level of evidence. Bias risk was evaluated using the Cochrane Bias tool and GRADE criteria. Medication, administration, adverse effects, pain scores, and rescue analgesic consumption were evaluated. A summary of evidence detailing benefits, harm, and cost was prepared. RESULTS: Thirty-two studies encompassing 1812 patients were included. The GRADE criteria determined the overall evidence to be of moderate quality. Perioperative acetaminophen had few adverse events and reduced immediate need for opioid rescue after sinus surgery; studies evaluating acetaminophen demonstrate a preponderance of benefit over harm. Nonsteroidal anti-inflammatory drugs (NSAIDs) also reduce postoperative opioid consumption, although a small portion of patients undergoing sinus surgery harbor the potential for NSAID intolerance. The aggregate level of evidence for studies evaluating NSAIDs was grade A, whereas the aggregate grade of evidence for several other agents was grade B. CONCLUSION: There is evidence supporting the use of NSAIDs and gabapentin for the control of pain after endoscopic sinus surgery. Acetaminophen, α-agonists, and local anesthetics are also viable options for postoperative analgesia. Familiarity with these data is essential to facilitate the use of opioid alternatives. Further large-scale, multi-institutional, randomized trials are needed to provide conclusive recommendations for these perioperative analgesics.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Svider PF, Nguyen B, Yuhan B, et al. Perioperative analgesia for patients undergoing endoscopic sinus surgery: an evidence-based review. Int Forum Allergy Rhinol. 2018. PMID: 29645361. doi:10.1002/alr.22107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。